Breakthrough Hydrogel Delivers Oxygen to Heal Chronic Wounds Faster

Scientists at the University of California, Riverside have created a new hydrogel that delivers oxygen directly to chronic wounds. This innovation aims to speed up healing for injuries that often resist treatment. Chronic wounds, which last longer than a month, affect millions globally and can lead to severe complications, including amputation in one in five cases.

Chronic wounds fail to heal normally due to prolonged inflammation and tissue damage. A key issue is hypoxia—low oxygen levels deep within the injury—which delays recovery and worsens tissue breakdown. Current treatments often address symptoms rather than the root cause.

The UC Riverside team developed a hydrogel that combines a choline-based liquid with a soft, water-rich polymer. This material moulds to the wound's shape, ensuring precise oxygen delivery where it's needed most. A tiny battery triggers water-splitting reactions inside the gel, releasing oxygen steadily over time to support healing.

Preclinical tests on diabetic and elderly mice showed remarkable results. Wounds treated with the hydrogel closed in about 23 days, a major improvement over untreated cases. The gel also reduces oxidative stress and boosts tissue regeneration, thanks to choline's immunomodulatory effects.

Unlike traditional therapies, this approach uses bioelectrochemistry to tackle hypoxia directly. The method represents a significant shift in how chronic wounds could be managed in the future.

As of 2026, the technology remains in preclinical trials. If successful in human studies (Phases I-III), it may take another 5–10 years to gain FDA or EMA approval, potentially reaching hospitals between 2031 and 2036.

The hydrogel's ability to deliver oxygen continuously and reduce inflammation offers hope for millions suffering from chronic wounds. If approved, it could drastically cut healing times and lower the risk of amputations. The next step depends on clinical trials to confirm its safety and effectiveness in humans.